analyst
CA
AMEX · CATX
Perspective Therapeutics, Inc.
Healthcare · Medical - Devices
$2.73
Down-$0.19 (-6.35%)
Updated Sep 16, 2026, 12:24 PM
SID Score
3.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 200.3M
- P/E ratio
- -1.68
- Dividend yield
- 0.00%
- 52-week range
- $1.96 – $6.16
- Volume
- 1.47M
- Avg. volume
- 1.55M
Price performance
CATX price history
1M range · 20 trading sessions · Daily adjusted prices
CATX closed at $2.73 after 20 trading sessions, down 14.95% for the selected period.
- Last close
- $2.73
- Period change
- -14.95%
- Period low
- $2.73
- Period high
- $3.48
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $2.88 | $2.89 | $2.66 | $2.73 | 1.47M |
| Sep 14, 2026 | $2.81 | $2.96 | $2.79 | $2.92 | 2.02M |
| Sep 11, 2026 | $2.77 | $2.825 | $2.665 | $2.81 | 2.02M |
| Sep 10, 2026 | $2.96 | $3.01 | $2.75 | $2.77 | 1.58M |
| Sep 9, 2026 | $3.07 | $3.1075 | $2.96 | $2.99 | 1.5M |
| Sep 8, 2026 | $3.12 | $3.18 | $3.02 | $3.12 | 1.06M |
| Sep 4, 2026 | $3.07 | $3.18 | $3.025 | $3.13 | 1.37M |
| Sep 3, 2026 | $3.09 | $3.14 | $3.03 | $3.12 | 931.7K |
| Sep 2, 2026 | $3.10 | $3.235 | $3.025 | $3.10 | 864.64K |
| Sep 1, 2026 | $3.16 | $3.165 | $3.07 | $3.10 | 705.84K |
| Aug 31, 2026 | $3.11 | $3.18 | $3.08 | $3.16 | 910.73K |
| Aug 28, 2026 | $3.16 | $3.17 | $3.075 | $3.11 | 913.34K |
| Aug 27, 2026 | $3.15 | $3.24 | $3.10 | $3.18 | 797.53K |
| Aug 26, 2026 | $3.28 | $3.30 | $3.14 | $3.16 | 799.22K |
| Aug 25, 2026 | $3.22 | $3.325 | $3.20 | $3.29 | 773.77K |
| Aug 24, 2026 | $3.32 | $3.37 | $3.13 | $3.19 | 678.66K |
| Aug 21, 2026 | $3.25 | $3.435 | $3.2223 | $3.30 | 1.14M |
| Aug 20, 2026 | $3.46 | $3.56 | $3.18 | $3.21 | 1.18M |
| Aug 19, 2026 | $3.31 | $3.50 | $3.30 | $3.48 | 1.75M |
| Aug 18, 2026 | $3.21 | $3.25 | $3.125 | $3.21 | 757.95K |
Latest CATX news
The latest Smart Investors Daily articles mentioning CATX.
Stock researchMarket Activity · Institutional Ownership
Loading stock research…